Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
4.920
-0.040 (-0.81%)
At close: Mar 12, 2026, 4:00 PM EDT
4.970
+0.050 (1.02%)
After-hours: Mar 12, 2026, 5:50 PM EDT

Rocket Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
77.56163.6455.9140.52232.69
Short-Term Investments
111.37208.7317.27215.88156.05
Cash & Short-Term Investments
188.93372.34373.18356.39388.74
Cash Growth
-49.26%-0.22%4.71%-8.32%-19.47%
Other Current Assets
3.815.855.057.673.32
Total Current Assets
192.73378.18378.22364.06392.06
Net Property, Plant & Equipment
71.5983.3287.5977.6572.35
Other Intangible Assets
25.1525.1525.1525.72-
Goodwill
39.1539.1539.1539.1530.82
Long-Term Investments
--34.3243.28-
Other Long-Term Assets
1.821.891.911.951.8
Total Assets
330.45527.7566.34551.81497.02
Accounts Payable
27.2937.8345.7936.6619.62
Current Portion of Leases
2.922.862.722.512.55
Total Current Liabilities
30.2140.6848.5139.1722.17
Long-Term Leases
21.9622.6422.3320.3620.05
Other Long-Term Liabilities
1.061.142.942.60.08
Total Long-Term Liabilities
23.0223.7825.2622.9520.13
Total Liabilities
53.2364.4773.7762.1242.3
Common Stock
1.081.070.90.790.65
Treasury Stock
----0.05-
Additional Paid-in Capital
1,7171,6801,4511,203946.15
Accumulated Other Comprehensive Income
-0.030.070.32-0.36-0.16
Retained Earnings
-1,441-1,218-959.37-713.78-491.91
Shareholders' Equity
277.22463.23492.57489.69454.72
Total Liabilities & Equity
330.45527.7566.34551.81497.02
Total Debt
24.8825.525.0422.8722.6
Net Cash (Debt)
164.05346.84348.13333.53366.14
Net Cash Growth
-52.70%-0.37%4.38%-8.91%-13.04%
Net Cash Per Share
1.483.664.144.895.79
Book Value
277.22463.23492.57489.69454.72
Book Value Per Share
2.494.895.867.197.19
Tangible Book Value
212.92398.93428.27424.81423.91
Tangible Book Value Per Share
1.924.215.106.236.70
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q